Aster Capital Management’s Oruka Therapeutics ORKA Stock Holding History
Bought
Maintained
Sold
Other funds holding ORKA
Aster Capital Management's ORKA Position: Q3 2026 in Review
Aster Capital Management sold out of Oruka Therapeutics (ORKA) in Q3 2026, closing a stake of 105 shares — an estimated $10K sold.
Aster Capital Management first reported a position in ORKA in Q4 2024 and held it in 3 quarters. The position peaked at $10K in Q2 2026. 259 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.
- Aster Capital Management reported no remaining Oruka Therapeutics position as of Q3 2026 after selling out during the quarter.
- Aster Capital Management sold 105 Oruka Therapeutics shares in Q3 2026, an estimated $10K.
- Aster Capital Management first reported a position in Oruka Therapeutics in Q4 2024 and held it in 3 quarters.
- Aster Capital Management's Oruka Therapeutics position peaked at $10K in Q2 2026.
- 259 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.
Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.